Literature DB >> 1953683

A polyclonal antibody preparation with Michaelian catalytic properties.

G Gallacher1, C S Jackson, M Searcey, G T Badman, R Goel, C M Topham, G W Mellor, K Brocklehurst.   

Abstract

1. 4-Nitrophenyl 4'-(3-aza-2-oxoheptyl)phenyl carbonate (I), an amide conjugate (XI) involving the carboxy group of 4-nitrophenyl 4'-carboxymethylphenyl phosphate and an amino group of keyhole-limpet haemocyanin, and a fluorescein derivative (XVII) were synthesized. 2. The conjugate (XI) was used as an immunogen with which to raise polyclonal antibodies in multigeneration cross-bred sheep; the fluorescent derivative (XVII) was used for the initial assessment of the antisera via binding assays monitored by fluorescence polarization; the carbonate ester (I) was used as a chromogenic substrate for the investigation of catalytic activity. 3. The IgG from the antiserum of sheep no. 270 was isolated by Na2SO4 precipitation and chromatography on Protein G-Sepharose. 4. This preparation of IgG catalysed the hydrolysis of the carbonate ester (I); the catalysis at pH 8.0 and 25 degrees C obeyed Michaelis-Menten kinetics with at least 25 turnovers, Km = 3.34 microM, and lower limits for kcat. of 0.029 s-1 and for kcat./Km of 8.77 x 10(3) M-1.S-1, on the unlikely assumption that the concentration of catalytic antibody is provided by twice the total IgG concentration (two sites per molecule); probable estimates of the fraction of the total IgG that is anti-haptenic IgG and of the fraction of this that is catalytically active suggest that the values of kcat./Km are actually very much larger than these lower limits. 5. The failure of the antibody preparation to catalyse the hydrolysis of the isomeric 2-nitrophenyl carbonate (II), which differs from compound (I) only in the position of the nitro substituent in the leaving group, compels the view that catalytic activity is due to antibody rather than contaminant enzyme; this conclusion is supported by (a) the failure of the following to discriminate effectively between the isomeric substrates (I) and (II): pig liver carboxylesterase, rabbit liver carboxylesterase (collectively EC 3.1.1.1), whole serum from a non-immunized sheep and whole serum from a sheep immunized with a derivative of 3-O-methylnoradrenaline and (b) the lack of catalytic activity in IgG preparations from sheep immunized with sulphoxide or sulphone analogues of immunogen (XI). 6. The various parameters used for the comparison of the kinetic characteristics of hydrolytic catalytic antibodies are discussed. 7. The characteristics of hydrolysis of compound (I) catalysed by the present polyclonal antibody preparation are shown to be substantially better in most respects than those of analogous reactions of two other carbonate esters catalysed by monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1953683      PMCID: PMC1151527          DOI: 10.1042/bj2790871

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

2.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

3.  Polyclonal-antibody-catalysed hydrolysis of an aryl nitrophenyl carbonate.

Authors:  G Gallacher; C S Jackson; C M Topham; M Searcey; B C Turner; G T Badman; K Brocklehurst
Journal:  Biochem Soc Trans       Date:  1990-08       Impact factor: 5.407

4.  Appendix: Analysis of pH-dependent kinetics in up to four reactive hydronic states.

Authors:  S M Brocklehurst; K Brocklehurst
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

Review 5.  Tinkering with enzymes: what are we learning?

Authors:  J R Knowles
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

6.  Catalytic antibodies.

Authors:  A Tramontano; K D Janda; R A Lerner
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

7.  Supracrystallographic resolution of interactions contributing to enzyme catalysis by use of natural structural variants and reactivity-probe kinetics.

Authors:  K Brocklehurst; S M Brocklehurst; D Kowlessur; M O'Driscoll; G Patel; E Salih; W Templeton; E Thomas; C M Topham; F Willenbrock
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

8.  The interplay between chemistry and biology in the design of enzymatic catalysts.

Authors:  P G Schultz
Journal:  Science       Date:  1988-04-22       Impact factor: 47.728

9.  The synthesis of co-polymers with pendant functional groups arranged in a predetermined geometry as enzyme models [proceedings].

Authors:  V W Pike; C W Wharton; K Brocklehurst; E M Crook
Journal:  Biochem Soc Trans       Date:  1978       Impact factor: 5.407

10.  Consequences of molecular recognition in the S1-S2 intersubsite region of papain for catalytic-site chemistry. Change in pH-dependence characteristics and generation of an inverse solvent kinetic isotope effect by introduction of a P1-P2 amide bond into a two-protonic-state reactivity probe.

Authors:  K Brocklehurst; D Kowlessur; G Patel; W Templeton; K Quigley; E W Thomas; C W Wharton; F Willenbrock; R J Szawelski
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

View more
  11 in total

1.  A general kinetic approach to investigation of active-site availability in macromolecular catalysts.

Authors:  M Resmini; S Gul; S Carter; S Sonkaria; C M Topham; G Gallacher; K Brocklehurst
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.

Authors:  Sanjiv Sonkaria; Guillaume Boucher; José Flórez-Olvarez; Bilal Said; Syeed Hussain; Elizabeth L Ostler; Sheraz Gul; Emrys W Thomas; Marina Resmini; Gerard Gallacher; Keith Brocklehurst
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

3.  Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.

Authors:  Sheraz Gul; Sanjiv Sonkaria; Surapong Pinitglang; José Florez-Alvarez; Syeed Hussain; Emrys W Thomas; Elizabeth L Ostler; Gerard Gallacher; Marina Resmini; Keith Brocklehurst
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

4.  Polyclonal antibody catalytic variability.

Authors:  D B Stephens; R E Thomas; J F Stanton; B L Iverson
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

Review 5.  Hapten design for the generation of catalytic antibodies.

Authors:  N R Thomas
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

6.  An active immunization approach to generate protective catalytic antibodies.

Authors:  J Wang; Y Han; M F Wilkinson
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

7.  Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.

Authors:  Guillaume Boucher; Bilal Said; Elizabeth L Ostler; Marina Resmini; Keith Brocklehurst; Gerard Gallacher
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

8.  Polyclonal antibody-catalysed amide hydrolysis.

Authors:  G Gallacher; M Searcey; C S Jackson; K Brocklehurst
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

9.  Characterization of the hydrolytic activity of a polyclonal catalytic antibody preparation by pH-dependence and chemical modification studies: evidence for the involvement of Tyr and Arg side chains as hydrogen-bond donors.

Authors:  M Resmini; R Vigna; C Simms; N J Barber; E P Hagi-Pavli; A B Watts; C Verma; G Gallacher; K Brocklehurst
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

10.  AB 3.1.1.1 (or EC 3.1.1.?).

Authors: 
Journal:  Eur J Biochem       Date:  2004-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.